Find the Right Market Report

Search thousands of industry reports, market insights, and research studies in one place.

Not sure where to start? Try one of these:
Explore healthcare market intelligence and industry insights
Towards Healthcare

Neurodiagnostics Companies and Strategic Expansion Initiatives 2026

Date : 11 March 2026

Latest Updates of Key Players in the Neurodiagnostics Market with Growth 2026-2035

Neurodiagnostics Market Companies are Canon Medical Systems Corporation, Siemens Healthineers AG, Koninklijke Philips N.V., Thermo Fisher Scientific, Inc

Company Latest Updates

Company Headquarters Latest Update
Canon Medical Systems Corporation United States In November 2025, Canon Medical Systems USA, Inc. recently received FDA 510 clearance for its Aplio i-series diagnostic ultrasound systems with Software Version 9.0.
Siemens Healthineers AG Germany Siemens Healthineers is increasing innovation by developing new blood-based biomarker assays for both healthcare use and neuroscience studies.
Koninklijke Philips N.V. Netherlands In November 2025, Royal Philips, a worldwide leader in health technology, announced an increasing collaboration with Cortechs.ai, a pioneer in quantitative neuroimaging services.
Thermo Fisher Scientific, Inc. United States Thermo Fisher Scientific is massively focused on increasing its AI-based medicine development, high-throughput imaging, and advanced diagnostics, specifically via the acquisition of Clario and the Olink Explore Platform.
FUJIFILM Corporation United States In October 2025, FUJIFILM Corporation announced plans to open the NURA health screening center, focusing on cancer screening, in four major cities across ASEAN: Ho Chi Minh City (Vietnam), Bangkok (Thailand), Manila (Philippines), and Kuala Lumpur (Malaysia).
Natus Medical Incorporated United States In December 2025, Natus Medical Incorporated announced the electrographic status epilepticus diagnosis ability of its BrainWatch point-of-care EEG services, featuring integrated Persyst analysis software, which has received 510(k) authorization from the U.S. Food and Drug Administration.

Supply Chain Analysis

R&D:

  • Research and Development (R&D) in neurodiagnostics includes a multidisciplinary, multi-stage technology goal to create, enhance, and validate devices to identify neurological conditions earlier and more exactly.
  • Key Players: Abbott Laboratories and Canon

Manufacturing Processes:

  • Manufacturing processes in neurodiagnostics involve a wide range of high-accuracy processes designed to create sensitive sensors, imaging tools, and implantable tools to assess the nervous system.
  • Key Players: Philips Healthcare and Natus Medical

Patient Services:

  • Patient services for neurodiagnostics involve diagnostic testing procedures, imaging services, procedural and specialized services, patient care, and safety protocols
  • Key Players: Siemens Healthineers and GE Healthcare

Market Growth

The global neurodiagnostics market size was estimated at USD 19.05 billion in 2025 and is predicted to increase from USD 20.68 billion in 2026 to approximately USD 43.27 billion by 2035, expanding at a CAGR of 8.55% from 2026 to 2035.

Neurodiagnostics Market Size is USD 20.68 Billion in 2026.

Recent Developments in the Neurodiagnostics Market

  • In November 2025, RapidAI, the inventor of deep clinical AI and worldwide leader in enterprise imaging, announced U.S. Food and Drug Administration (FDA) clearance of Aortic Management, part of the Rapid Aortic product, a comprehensive deep clinical AI service designed to transform the acute assessment and longitudinal management of aortic disease.
  • In September 2025, Natus Medical Incorporated, the largest worldwide pure-play neurodiagnostics organization, announced it had acquired the remaining minority shares in Holberg EEG, the ground-breaking developer of the world's first artificial intelligence (AI) model capable of automatic and inclusive clinical EEG interpretation with precision on par with leading medical specialists.
  • In April 2025, a global leader in neurodiagnostic, neuromonitoring, and sleep solutions, Cadwell Industries, Inc., announced its strategic investment in Seer Medical, a Melbourne, Australia-driven organization specializing in home-based epilepsy diagnostics. The investment was made in collaboration with investors Breakthrough Victoria and TrialCap.

Experience a customized Neurodiagnostics Market report that understands your business needs for Free: Download Now

Ready to make better
healthcare business decisions?

Speak with a healthcare analyst about your research, consulting, or platform needs.

Talk to an Analyst Contact Sales